Intracellular cytoplasmic chelating sites

Intracellular cytoplasmic chelating sites is a descriptive term rather than a specific molecular entity or canonical biological target. It refers to the various locations and molecules within the cytoplasm, such as the labile iron pool or metallothioneins, where metal ions are available to be bound by endogenous or exogenous chelating agents. In a therapeutic context, these sites are the functional destination for iron-chelating drugs like deferiprone or deferoxamine, which must enter the intracellular environment to sequester toxic accumulations of free metals. Because this term encompasses a broad range of non-specific binding environments and various proteins, it does not meet the criteria for a single, well-defined therapeutic target. Instead, it represents a physiological compartment involved in metal ion homeostasis and the mitigation of oxidative stress caused by metal-catalyzed radical formation.

Other names

Cytoplasmic metal binding sitesIntracellular chelation sites

Chelation of free or loosely bound metal ions within the cytoplasmic compartment to prevent oxidative damage and facilitate excretion.